n-methylaspartate has been researched along with oxidopamine in 43 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (4.65) | 18.7374 |
1990's | 21 (48.84) | 18.2507 |
2000's | 15 (34.88) | 29.6817 |
2010's | 5 (11.63) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Weissenborn, R; Winn, P | 1 |
Abreu, M; Ferkany, J; French, ED; Levenson, S | 1 |
Browning, RA; Faingold, CL; Wang, C | 1 |
Di Chiara, G; Morelli, M | 1 |
Chapman, AG; Dürmuller, N; Lees, GJ; Meldrum, BS | 1 |
Beart, PM; Christie, MJ; Gibson, SJ; Louis, WJ; Papasava, M; Singer, G | 1 |
Alhaider, AA; Hamon, M; Wilcox, GL | 1 |
Ossowska, K | 1 |
Gancher, S; Mayer, A | 1 |
Bédard, PJ; St-Pierre, JA | 1 |
Daszuta, A; Forni, C; Moukhles, H; Nieoullon, A | 1 |
Boldry, RC; Chase, TN; Engber, TM | 1 |
Monard, D; Nitsch, C; Scotti, AL | 1 |
Kondoh, T; Low, WC | 1 |
Kerkerian-Le Goff, L; Nieoullon, A; Salin, P | 1 |
Ahlers, ST; Bragin, V; Davis, KL; Gluck, R; Gotlib, J; Haroutunian, V; Shea, PA; Sugar, J; Wallace, W | 1 |
Brudzynski, SM; Wu, M | 1 |
Klockgether, T; Löschmann, PA; Petersen, V; Steinbach, JP; Turski, L; Wüllner, U | 1 |
Blaha, CD; Phillips, AG; Weissenborn, R; Winn, P | 1 |
Carta, A; Di Chiara, G; Fenu, S; Morelli, M | 1 |
Nishikawa, T; Takahashi, K; Umino, A; Yoshida, Y | 1 |
Beani, L; Bianchi, C; Fuxe, K; Marti, M; Morari, M; Sbrenna, S | 1 |
Agid, Y; Hirsch, EC; Jimenez, A; Marin, C; Raisman-Vozari, R; Ruberg, M; Tolosa, E; Vila, M | 1 |
Fisone, G; Goiny, M; Goldstein, M; Haycock, J; Herrera-Marschitz, M; Hökfelt, T; Lindgren, N; Lindskog, M; Xu, ZQ | 1 |
Brotchie, JM; Nash, JE | 1 |
Glowinski, J; Godeheu, G; Kemel, ML; Pérez, S; Soubrié, P | 1 |
Archer, T; Fredriksson, A | 1 |
Beani, L; Bianchi, C; Marti, M; Mela, F; Morari, M | 1 |
Grijalva, CV; Landeira-Fernandez, J | 1 |
Alonso, TJ; Castro Fuentes, R; García Dopico, J; González Hernández, T; Perdomo Díaz, J; Rodríguez Díaz, M | 1 |
Bianchi, C; Della Corte, L; Fantin, M; Manzalini, M; Marti, M; Morari, M | 1 |
Kress, GJ; Reynolds, IJ | 1 |
Allbutt, H; Billing, R; Doherty, K; Henderson, J | 1 |
Deniau, JM; Ezan, P; Glowinski, J; Jabourian, M; Kemel, ML; Pérez, S | 1 |
Ampe, B; D'Haens, J; Ebinger, G; Massie, A; Michotte, Y; Sarre, S | 1 |
Berger, SP; Brudney, EG; Johnson, SW; Meshul, CK; Paquette, MA; Putterman, DB | 1 |
Gray, TS; Mickiewicz, AL; Napier, TC; Turner, MS | 1 |
Allbutt, HN; Coster, MJ; Henderson, JM; Kassiou, M; Truong, L | 1 |
Bagetta, V; Bonito-Oliva, A; Calabresi, P; Carta, M; Di Luca, M; Errico, F; Fisone, G; Gardoni, F; Marinucci, S; Napolitano, F; Picconi, B; Romano, R; Usiello, A; Vitucci, D; Zianni, E | 1 |
Chao, OY; Huston, JP; Pum, ME | 1 |
Chao, OY; de Souza Silva, MA; Huston, JP; Petri, D; Schnitzler, A | 1 |
Kreitzer, AC; Lalive, AL; Parker, PR | 1 |
Dragon, DN; Lin, LH; Talman, WT | 1 |
1 review(s) available for n-methylaspartate and oxidopamine
Article | Year |
---|---|
The role of excitatory amino acids in experimental models of Parkinson's disease.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amphetamine; Animals; Catalepsy; Disease Models, Animal; Excitatory Amino Acids; Levodopa; N-Methylaspartate; Oxidopamine; Parkinson Disease; Rats | 1994 |
42 other study(ies) available for n-methylaspartate and oxidopamine
Article | Year |
---|---|
Regulatory behaviour, exploration and locomotion following NMDA or 6-OHDA lesions in the rat nucleus accumbens.
Topics: Animals; Apomorphine; Body Weight; Brain Mapping; Dextroamphetamine; Dopamine; Dose-Response Relationship, Drug; Drinking Behavior; Exploratory Behavior; Feeding Behavior; Limbic System; Locomotion; Male; Motor Activity; N-Methylaspartate; Neural Pathways; Nucleus Accumbens; Oxidopamine; Rats; Receptors, Dopamine; Stereotyped Behavior; Substantia Nigra; Tegmentum Mesencephali | 1992 |
Effects of competitive N-methyl-D-aspartate antagonists on midbrain dopamine neurons: an electrophysiological and behavioral comparison to phencyclidine.
Topics: Amino Acids; Amphetamine; Animals; Behavior, Animal; Dopamine; Electrophysiology; Limbic System; Male; Mesencephalon; Motor Activity; N-Methylaspartate; Neurons; Nucleus Accumbens; Oxidopamine; Phencyclidine; Pipecolic Acids; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate | 1991 |
Effect of norepinephrine depletion on audiogenic-like seizures elicited by microinfusion of an excitant amino acid into the inferior colliculus of normal rats.
Topics: Acoustic Stimulation; Animals; Brain; Hydroxydopamines; Inferior Colliculi; Infusions, Parenteral; Locus Coeruleus; Male; N-Methylaspartate; Norepinephrine; Oxidopamine; Rats; Rats, Inbred Strains; Reference Values; Seizures; Stereotaxic Techniques | 1991 |
Stereospecific blockade of N-methyl-D-aspartate transmission by MK 801 prevents priming of SKF 38393-induced turning.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Aspartic Acid; Dibenzocycloheptenes; Dizocilpine Maleate; Hydroxydopamines; Male; N-Methylaspartate; Oxidopamine; Rats; Rats, Inbred Strains; Stereoisomerism; Stereotyped Behavior; Sympathectomy, Chemical; Synaptic Transmission | 1990 |
Excitotoxicity of NMDA and kainic acid is modulated by nigrostriatal dopaminergic fibres.
Topics: Animals; Aspartic Acid; Choline O-Acetyltransferase; Corpus Striatum; Dopamine; Glutamate Decarboxylase; Hydroxydopamines; Kainic Acid; N-Methylaspartate; Oxidopamine; Rats; Rats, Inbred Strains; Substantia Nigra | 1989 |
6-Hydroxydopamine and excitotoxin lesions of medial prefrontal cortex fail to affect schedule-induced drinking in the rat.
Topics: Animals; Aspartic Acid; Brain Mapping; Dopamine; Drinking Behavior; Food Deprivation; Frontal Lobe; Hydroxydopamines; Male; N-Methylaspartate; Neural Pathways; Nucleus Accumbens; Oxidopamine; Rats; Reinforcement Schedule; Tegmentum Mesencephali | 1986 |
Intrathecal 5-methoxy-N,N-dimethyltryptamine in mice modulates 5-HT1 and 5-HT3 receptors.
Topics: Analgesics; Animals; Behavior, Animal; Binding, Competitive; Brain Chemistry; In Vitro Techniques; Injections, Spinal; Male; Methoxydimethyltryptamines; Mice; N-Methylaspartate; Nociceptors; Norepinephrine; Oxidopamine; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Substance P | 1993 |
Sensitization to apomorphine-induced rotational behavior in 6-OHDA-lesioned rats: effects of NMDA antagonists on drug response.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Dizocilpine Maleate; Dopamine Agonists; Excitatory Amino Acid Antagonists; Male; N-Methylaspartate; Oxidopamine; Piperazines; Rats; Rats, Sprague-Dawley; Rotation; Stereotyped Behavior; Sympathectomy, Chemical | 1995 |
Intranigral but not intrastriatal microinjection of the NMDA antagonist MK-801 induces contralateral circling in the 6-OHDA rat model.
Topics: Animals; Corpus Striatum; Dizocilpine Maleate; Female; Functional Laterality; Microinjections; Motor Activity; N-Methylaspartate; Oxidopamine; Prosencephalon; Rats; Rats, Sprague-Dawley; Stereotaxic Techniques; Substantia Nigra | 1994 |
Regulation of dopamine levels in intrastriatal grafts of fetal mesencephalic cell suspension: an in vivo voltammetric approach.
Topics: 2-Amino-5-phosphonovalerate; 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Benzazepines; Brain Tissue Transplantation; Cerebral Ventricles; Corpus Striatum; Dizocilpine Maleate; Dopamine; Dopamine D2 Receptor Antagonists; Female; Fetal Tissue Transplantation; Glutamic Acid; Injections, Intraventricular; Kinetics; Mesencephalon; N-Methylaspartate; Oxidopamine; Quisqualic Acid; Rats; Rats, Wistar; Receptors, Dopamine D1; Sulpiride; Time Factors; Transplantation, Heterotopic | 1994 |
Influence of previous exposure to levodopa on the interaction between dizocilpine and dopamine D1 and D2 agonists in rats with 6-hydroxydopamine-induced lesions.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Brain Diseases; Dizocilpine Maleate; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Levodopa; Male; Motor Activity; N-Methylaspartate; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1993 |
Re-expression of glia-derived nexin/protease nexin 1 depends on mode of lesion-induction or terminal degeneration: observations after excitotoxin or 6-hydroxydopamine lesions of rat substantia nigra.
Topics: Amyloid beta-Protein Precursor; Animals; Carrier Proteins; Glial Fibrillary Acidic Protein; Ibotenic Acid; Immunohistochemistry; Male; N-Methylaspartate; Nerve Degeneration; Oxidopamine; Protease Nexins; Putamen; Quisqualic Acid; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, Glutamate; Substantia Nigra; Tyrosine 3-Monooxygenase; Up-Regulation | 1994 |
Glutamate uptake blockade induces striatal dopamine release in 6-hydroxydopamine rats with intrastriatal grafts: evidence for host modulation of transplanted dopamine neurons.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Brain Diseases; Brain Tissue Transplantation; Corpus Striatum; Dopamine; Excitatory Amino Acid Antagonists; Glutamates; Glutamic Acid; Kainic Acid; Male; Mesencephalon; N-Methylaspartate; Neurons; Oxidopamine; Rats; Tyrosine 3-Monooxygenase | 1994 |
Reversal of the adaptive response of neuropeptide Y neurons in the rat striatum to nigrostriatal dopamine deafferentation by the N-methyl-D-aspartate antagonist dizocilpine maleate.
Topics: Adaptation, Physiological; Animals; Behavior, Animal; Dizocilpine Maleate; Female; Immunohistochemistry; N-Methylaspartate; Neostriatum; Neural Pathways; Neurons; Neurons, Afferent; Neuropeptide Y; Oxidopamine; Rats; Rats, Wistar; Substantia Nigra; Synaptic Transmission | 1994 |
Amyloid precursor protein in the cerebral cortex is rapidly and persistently induced by loss of subcortical innervation.
Topics: 5,7-Dihydroxytryptamine; Acetylcholine; Actins; Afferent Pathways; Amyloid beta-Protein Precursor; Animals; Cerebral Cortex; Choline O-Acetyltransferase; Diabetes Mellitus, Experimental; Functional Laterality; Glucocorticoids; Kinetics; Lidocaine; Male; N-Methylaspartate; Norepinephrine; Oxidopamine; Physostigmine; Polyribosomes; Raphe Nuclei; Rats; Rats, Sprague-Dawley; RNA, Messenger; Substantia Innominata; Time Factors | 1993 |
Mesolimbic dopamine terminals and locomotor activity induced from the subiculum.
Topics: Animals; Dopamine; Hippocampus; Locomotion; Male; N-Methylaspartate; Neural Pathways; Neurons; Nucleus Accumbens; Oxidopamine; Rats; Rats, Wistar | 1995 |
Effects of the antiparkinsonian drug budipine on central neurotransmitter systems.
Topics: Animals; Antiparkinson Agents; Biperiden; Central Nervous System; Dopamine; Excitatory Amino Acid Antagonists; Male; Mice; Microdialysis; Muscarinic Antagonists; N-Methylaspartate; Neostriatum; Neurotransmitter Agents; Oxidopamine; Piperazines; Piperidines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Rotation; Seizures; Stereotyped Behavior; Sympatholytics | 1996 |
Schedule-induced polydipsia and the nucleus accumbens: electrochemical measurements of dopamine efflux and effects of excitotoxic lesions in the core.
Topics: Animals; Calibration; Conditioning, Operant; Dopamine; Drinking Behavior; Electrochemistry; Excitatory Amino Acid Agonists; Food; Isotonic Solutions; Male; N-Methylaspartate; Nucleus Accumbens; Oxidopamine; Rats; Stereotaxic Techniques; Sympatholytics; Water Deprivation | 1996 |
Effect of MK 801 on priming of D1-dependent contralateral turning and its relationship to c-fos expression in the rat caudate-putamen.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Caudate Nucleus; Dizocilpine Maleate; Dopamine Agonists; Excitatory Amino Acid Antagonists; Immunohistochemistry; Male; N-Methylaspartate; Oxidopamine; Proto-Oncogene Proteins c-fos; Putamen; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereotyped Behavior; Sympathectomy, Chemical; Sympatholytics; Synaptic Transmission | 1996 |
Evidence for N-methyl-D-aspartate receptor-mediated increase in norepinephrine utilization in the prefrontal cortex of unanesthetized rats.
Topics: 2-Amino-5-phosphonovalerate; Adrenergic Agents; Animals; Binding, Competitive; Consciousness; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Male; Microinjections; N-Methylaspartate; Norepinephrine; Oxidopamine; Phencyclidine; Piperazines; Prefrontal Cortex; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Sympathomimetics; Tritium | 1997 |
In vitro evidence for increased facilitation of striatal acetylcholine release via pre- and postsynaptic NMDA receptors in hemiparkinsonian rats.
Topics: Acetylcholine; Animals; Corpus Striatum; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Male; N-Methylaspartate; Nerve Degeneration; Organ Culture Techniques; Oxidopamine; Parkinson Disease, Secondary; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Sympatholytics; Synaptosomes | 1999 |
Systemic administration of NMDA and AMPA receptor antagonists reverses the neurochemical changes induced by nigrostriatal denervation in basal ganglia.
Topics: Animals; Basal Ganglia; Corpus Striatum; Denervation; Dizocilpine Maleate; Dopamine; Electron Transport Complex IV; Excitatory Amino Acid Antagonists; Glutamate Decarboxylase; Isoquinolines; Levodopa; Male; N-Methylaspartate; Oxidopamine; Rats; Rats, Sprague-Dawley; Receptors, AMPA; RNA, Messenger; Substantia Nigra; Tetrazoles | 1999 |
Regulation of tyrosine hydroxylase activity and phosphorylation at Ser(19) and Ser(40) via activation of glutamate NMDA receptors in rat striatum.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Antibody Specificity; Catalytic Domain; Caudate Nucleus; Colforsin; Dihydroxyphenylalanine; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Glutamic Acid; In Vitro Techniques; Male; N-Methylaspartate; Neurons; Okadaic Acid; Oxidopamine; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Serine; Sympatholytics; Tyrosine 3-Monooxygenase | 2000 |
A common signaling pathway for striatal NMDA and adenosine A2a receptors: implications for the treatment of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Corpus Striatum; Cyclic AMP; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; In Vitro Techniques; Male; N-Methylaspartate; Neuroprotective Agents; Oxidopamine; Parkinson Disease, Secondary; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Receptors, N-Methyl-D-Aspartate; Receptors, Purinergic P1; Signal Transduction | 2000 |
Facilitation by endogenous tachykinins of the NMDA-evoked release of acetylcholine after acute and chronic suppression of dopaminergic transmission in the matrix of the rat striatum.
Topics: Acetylcholine; Animals; Benzamides; Corpus Striatum; Dopamine; Dopamine Antagonists; Enzyme Inhibitors; In Vitro Techniques; Male; N-Methylaspartate; Neural Inhibition; Neurons; Oxidopamine; Peptide Fragments; Piperidines; Pyrrolidonecarboxylic Acid; Quinuclidines; Rats; Rats, Sprague-Dawley; Receptors, Tachykinin; Substance P; Synaptic Transmission; Tachykinins; Time Factors | 2002 |
Functional alteration by NMDA antagonist: effects of L-Dopa, neuroleptics drug and postnatal administration.
Topics: Age Factors; Animals; Animals, Newborn; Antiparkinson Agents; Antipsychotic Agents; Excitatory Amino Acid Antagonists; Female; Humans; Levodopa; Male; Maze Learning; Mice; Mice, Inbred C57BL; Motor Activity; N-Methylaspartate; Oxidopamine; Parkinsonian Disorders; Pregnancy; Rats; Rats, Sprague-Dawley; Sympatholytics | 2002 |
Striatal dopamine-NMDA receptor interactions in the modulation of glutamate release in the substantia nigra pars reticulata in vivo: opposite role for D1 and D2 receptors.
Topics: Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Glutamic Acid; Male; Microdialysis; N-Methylaspartate; Oxidopamine; Parkinsonian Disorders; Perfusion; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Substantia Nigra; Wakefulness | 2002 |
Participation of the substantia nigra dopaminergic neurons in the occurrence of gastric mucosal erosions.
Topics: Acute-Phase Reaction; Analysis of Variance; Animals; Caudate Nucleus; Cell Death; Dopamine; Gastric Mucosa; Male; N-Methylaspartate; Neural Pathways; Neurons; Neurotoxins; Oxidopamine; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Stress, Psychological; Substantia Nigra; Ventral Tegmental Area | 2004 |
Extracellular taurine in the substantia nigra: taurine-glutamate interaction.
Topics: Adrenergic Agents; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Aspartic Acid; Brain Chemistry; Calcium; Chelating Agents; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Interactions; Egtazic Acid; Excitatory Amino Acid Antagonists; Extracellular Space; gamma-Aminobutyric Acid; Glutamic Acid; Kainic Acid; Ketamine; Male; Membrane Potentials; Microdialysis; N-Methylaspartate; Oxidopamine; Potassium; Rats; Rats, Sprague-Dawley; Substantia Nigra; Taurine; Time Factors; Zinc | 2004 |
Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine.
Topics: Adrenergic Agents; Animals; Benzazepines; Bicuculline; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; GABA Antagonists; Glutamic Acid; Magnesium; Male; N-Methylaspartate; Neurons; Oxidopamine; Piperidines; Potassium Chloride; Quinuclidines; Raclopride; Rats; Rats, Sprague-Dawley; Substance P; Substantia Nigra; Tetrodotoxin; Time Factors | 2005 |
Dopaminergic neurotoxins require excitotoxic stimulation in organotypic cultures.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Animals, Newborn; Brain; Cell Death; Cell Nucleus; Cerebral Cortex; Corpus Striatum; Dopamine; Drug Synergism; Glutamic Acid; N-Methylaspartate; Nerve Degeneration; Neurons; Neurotoxins; Organ Culture Techniques; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Rotenone; Substantia Nigra; Tyrosine 3-Monooxygenase | 2005 |
Effects of pallidotomy on motor symptoms in an animal model of Parkinson's disease.
Topics: Analysis of Variance; Animals; Disease Models, Animal; Female; Functional Laterality; Globus Pallidus; Medial Forebrain Bundle; Motor Activity; N-Methylaspartate; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Single-Blind Method; Statistics, Nonparametric; Tyrosine 3-Monooxygenase | 2006 |
Impact of 6-hydroxydopamine lesions and cocaine exposure on mu-opioid receptor expression and regulation of cholinergic transmission in the limbic-prefrontal territory of the rat dorsal striatum.
Topics: Acetylcholine; Animals; Behavior, Animal; Brain Injuries; Circadian Rhythm; Cocaine; Corpus Striatum; Dopamine Uptake Inhibitors; Drug Administration Schedule; Drug Interactions; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Excitatory Amino Acid Agonists; Functional Laterality; Male; Models, Neurological; N-Methylaspartate; Oxidopamine; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Tritium | 2007 |
NMDA-mediated release of glutamate and GABA in the subthalamic nucleus is mediated by dopamine: an in vivo microdialysis study in rats.
Topics: Animals; Dopamine; Dopamine Antagonists; Drug Interactions; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Extracellular Fluid; gamma-Aminobutyric Acid; Glutamic Acid; Male; Microdialysis; N-Methylaspartate; Neurons; Neurotoxins; Oxidopamine; Rats; Rats, Wistar; Receptors, Dopamine; Subthalamic Nucleus; Synaptic Transmission | 2007 |
Sigma ligands, but not N-methyl-D-aspartate antagonists, reduce levodopa-induced dyskinesias.
Topics: Adrenergic Agents; Amphetamine; Animals; Anti-Anxiety Agents; Behavior, Animal; Dextromethorphan; Disease Models, Animal; Dopamine Agents; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Levodopa; Ligands; Male; N-Methylaspartate; Neurotoxicity Syndromes; Oxidopamine; Pyrimidines; Rats; Rats, Sprague-Dawley; Time Factors | 2008 |
Fos expression following activation of the ventral pallidum in normal rats and in a model of Parkinson's Disease: implications for limbic system and basal ganglia interactions.
Topics: Animals; Basal Ganglia; Bicuculline; Brain; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; GABA Antagonists; Globus Pallidus; Immunohistochemistry; Limbic System; Male; Microinjections; N-Methylaspartate; Neurons; Oncogene Proteins v-fos; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Sympatholytics | 2008 |
Behavioural effects of a selective NMDA NR1A/2B receptor antagonist in rats with unilateral 6-OHDA+parafascicular lesions.
Topics: Administration, Oral; Adrenergic Agents; Animals; Antiparkinson Agents; Behavior, Animal; Disease Models, Animal; Dopamine; Excitatory Amino Acid Antagonists; Female; Immunohistochemistry; Intralaminar Thalamic Nuclei; Levodopa; Medial Forebrain Bundle; N-Methylaspartate; Neurons; Oxidopamine; Parkinson Disease, Secondary; Postural Balance; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Rotation; Tyrosine 3-Monooxygenase | 2009 |
Higher free D-aspartate and N-methyl-D-aspartate levels prevent striatal depotentiation and anticipate L-DOPA-induced dyskinesia.
Topics: Action Potentials; Animals; Antiparkinson Agents; Corpus Striatum; D-Aspartate Oxidase; D-Aspartic Acid; Dyskinesia, Drug-Induced; Extracellular Signal-Regulated MAP Kinases; Levodopa; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; N-Methylaspartate; Neuronal Plasticity; Oxidopamine; Parkinsonian Disorders; Phosphorylation; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Sympatholytics; Synapses | 2011 |
The interaction between the dopaminergic forebrain projections and the medial prefrontal cortex is critical for memory of objects: implications for Parkinson's disease.
Topics: Animals; Body Weight; Dark Adaptation; Dopamine; Excitatory Amino Acid Agonists; Exploratory Behavior; Functional Laterality; Hand Strength; Male; Maze Learning; Medial Forebrain Bundle; Memory; N-Methylaspartate; Neural Pathways; Oxidopamine; Prefrontal Cortex; Psychomotor Performance; Rats; Rats, Wistar; Recognition, Psychology; Serotonin; Space Perception; Sympatholytics | 2013 |
Serotonergic interaction between medial prefrontal cortex and mesotelencephalic DA system underlies cognitive and affective deficits in hemiparkinsonian rats.
Topics: Adrenergic Agents; Animals; Cognition Disorders; Disease Models, Animal; Excitatory Amino Acid Agonists; Functional Laterality; Male; Maze Learning; Mood Disorders; Motor Activity; N-Methylaspartate; Oxidopamine; Parkinsonian Disorders; Prefrontal Cortex; Rats; Rats, Wistar; Sensory Gating; Telencephalon | 2015 |
Pathway-Specific Remodeling of Thalamostriatal Synapses in Parkinsonian Mice.
Topics: Adrenergic Agents; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Corpus Striatum; Disease Models, Animal; Excitatory Amino Acid Agonists; Excitatory Postsynaptic Potentials; Exploratory Behavior; Functional Laterality; Homeodomain Proteins; Medial Forebrain Bundle; Mice; N-Methylaspartate; Neural Pathways; Oxidopamine; Parkinsonian Disorders; Synapses; Thalamus; Transcription Factors; Tyrosine 3-Monooxygenase; Vesicular Glutamate Transport Protein 2 | 2016 |
Reduced responses to glutamate receptor agonists follow loss of astrocytes and astroglial glutamate markers in the nucleus tractus solitarii.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Arterial Pressure; Astrocytes; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Excitatory Amino Acid Transporter 2; Excitatory Amino Acid Transporter 3; Heart Rate; Immunotoxins; Male; N-Methylaspartate; Neurons; Oxidopamine; Rats; Rats, Sprague-Dawley; Ribosome Inactivating Proteins, Type 1; Saporins; Solitary Nucleus; Synaptic Transmission; Vesicular Glutamate Transport Protein 2 | 2017 |